
COURSE CREDITS & HOURS
16 AMA PRA Category 1 Credits™16 ACPE Credits
16 (part II) MOC points in medical knowledge in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
8 Hours of Pharmacology for Nurse Practitioners
16.0 Contact Hours
COURSE FEES
$995 for Physicians, Attorneys, Psychologists, Pharmacists, & Dentists$795 for Physician Assistants & Nurse Practitioners
$595 for Nurses, Students & Others
TARGET AUDIENCE
PROGRAM PURPOSE
- COPD
- Discuss GOLD 2023Guidelines for Staging COPD
- Discuss GOLD 2023 Guidelines for COPD management
- Discuss the ACCP and Canadian Thoracic Society published guidelines for prevention of acute exacerbations of COPD
- Discuss the data that shaped these guidelines as related to:
- Medication Recommendations
- Non-medications Recommendations
- Discuss data on surgical and non-surgical lung volume reduction in patients with COPD.
- Discuss data on NIV for stable and acute COPD management
- Discuss New areas of investigation.
- Asthma
- Discuss the prevalence and economic impact of asthma
- Examine the pathophysiology of asthma
- Discuss strategies for management of asthma patients with acute respiratory failure
- Discuss expert consensus recommendations and application of these recommendations for accessing asthma control and disease management
- Discuss updated expert consensus recommendations for long term asthma management
- Examine data on recently FDA approved medications and bronchoscopic interventions used to treat severe persistent asthma
- Pulmonary Nodules and Lung Cancer Screening: Understanding and Applying the Society Recommendations
- Describe characteristics of pulmonary nodules that influence clinical suspicion for benign versus malignant
- Discuss the Fleischner Society Guideline recommendations for following incidental pulmonary nodules noted on CT scans of the chest
- Discuss Lung Cancer Screening Guidelines.
- Discuss Lung-RADS: the structured reporting system for interpretation of lung cancer screening CT examinations. Understand the difference in the Fleischner Guidelines and Lung Cancer Screening guidelines as related to nodule management
- Discuss diagnosis and staging of lung cancer
- Brief discussion of lung cancer treatment
- Acute Hypoxic Respiratory Failure and Acute Respiratory Distress Syndrome Clinical Update
- Review updated definition of ARDS
- Discuss risk factors for developing ARDS as well as the differential diagnosis of patients presenting with acute hypoxic respiratory failure and bilateral pulmonary infiltrates
- Examine data on the use of non-invasive ventilation and high flow nasal cannula for management patients with hypoxic respiratory failure. Recognize clinical parameters suggesting failure of these modes of respiratory support
- Understand the current recommendations regarding mechanical ventilation and management of patients with ARDS.
- Discuss the benefits and how to implement alternative treatments in patients with severe ARDS including: prone positioning, ECMO, paralytics, and vasodilators
- Pulmonary Embolism: Treating Patients Based on Risk Stratification, Evidence-Based Guidelines
- Discuss the Risk Stratification for Acute Pulmonary Embolism
- Identify Clinical Tools, Radiological Imaging, and Laboratory Markers Used in Risk Stratification of Acute Pulmonary Embolism
- Discuss Current ACCP Recommendations for Treatment of Acute Pulmonary Embolism
- Discuss Data on Treatment Outcomes of Patients with High and Intermediate Risk Acute Pulmonary Embolism Treated with Thrombolyis, Catheter Directed Thrombolyis, and Standard Anticoagulation
- Discuss Data on Long Term Follow-up from Patients with High and Intermediate Risk PE Treated with Thrombolysis versus Standard Anticoagulation
- Review Current ACCP Recommendation for Duration of Treatment of Acute Pulmonary Embolism
- Sleep Apnea Treatment Options: PAP, PACERS, and Beyond
- Discuss the clinical benefit of weight loss and positional sleep therapy as treatment for OSA
- Discuss data on medical interventions as related to treatment for OSA
- Discuss data on Provent nasal device as related to treatment of OSA
- Discuss data on dental devices as related to treatment for OSA
- Discuss data on various surgical interventions as related to treatment of OSA
- Discuss data on use of upper-airway stimulators for treatment of sleep apnea
- Discuss data on use of diaphragm pacing in patients with central sleep apnea
- Interstitial Lung Disease Part 1: Idiopathic Pulmonary Fibrosis and Sarcoid.
- Discuss the broad differential diagnosis of diffuse parenchymal lung disease
- Discuss the ATS/ERS diagnostic criteria for IPF and CT findings characteristic of IPF
- Understand the various clinical measures predictive of survival in IPF
- Discuss data that resulted in FDA approval for two drugs for treatment of IPF
- Discuss the ATS/ERS guidelines for treatment of IPF
- Understand the clinical presentation of pulmonary sarcoidosis.
- Discuss the ERS clinical practice guidelines for treatment of sarcoidosis as related to organ involvement
- Interstitial Lung Disease Part 2: Hypersensitivity Pneumonitis and Non-Cystic Fibrosis Bronchiectasis
- DiscussATS/ERS practice guidelines for diagnosis and management of hypersensitivity pneumonitis
- Examine CT findings for fibrotic and non-fibrotic HP
- Discuss the pathogenesis of Non-Cystic Fibrosis bronchiectasis
- Explain the work-up to determine the etiology of non-CF bronchiectasis
- Discuss how to manage patients with non-CF bronchiectasis
- Discuss management strategies in patients with acute exacerbations of non-CF bronchiectasis
IMPORTANT INFORMATION
Register your interest and receive a full quote at 800-422-0711 (US/Can) or direct/int'l tel: +1-727-526-1571 or register online.
Conference Sessions generally take place on days at sea (as itinerary allows), giving you plenty of time to enjoy your meals, evenings and ports of call with your companion, family and friends.